2017
CMET-07. VISMODEGIB TREATMENT OF INTRACRANIAL INVASION OF BASAL CELL CARCINOMA
Jameyfield E, Blondin N. CMET-07. VISMODEGIB TREATMENT OF INTRACRANIAL INVASION OF BASAL CELL CARCINOMA. Neuro-Oncology 2017, 19: vi40-vi40. PMCID: PMC5691966, DOI: 10.1093/neuonc/nox168.156.Peer-Reviewed Original ResearchMetastatic basal cell carcinomaBasal cell carcinomaCell carcinomaIntracranial invasionInitial treatmentNeurological symptomsScalp woundsVismodegib treatmentScalp basal cell carcinomasMonths of treatmentBest treatment optionYear old manLeft frontal lobeFurther medical attentionFocal cerebritisAge 78BCC patientsIncomplete resectionComplete responseScalp lesionsIntracranial complicationsTreatment optionsVasogenic edemaMohs surgeryPrevalent cancer
2014
Primary CNS Lymphoma
Blondin N, Baehring J, Hochberg F. Primary CNS Lymphoma. 2014, 308-315. DOI: 10.1002/9781118589199.ch48.Peer-Reviewed Original ResearchPrimary CNS lymphomaCNS lymphomaPrimary central nervous system lymphomaCentral nervous system lymphomaNervous system lymphomaCerebral biopsyIntrathecal chemotherapySystem lymphomaInitial treatmentOcular lymphomaDifferential diagnosisRadiation therapyBrain tumorsLymphomaPatientsCurrent standardCorticosteroidsChemotherapyBiopsyPrognosisTherapyTumorsMultiple-choice questionsDiagnosisCare